Cardiovascular risk factors and electrographical characteristics and abnormalities in middle-aged males

Journal of Internal Medicine

Volumn 241, Issue 2, 1997, Pages 109-113

  Lind, L ^a   Sundstrom J ^a   Lithell, H ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cholesterol; Coronary heart disease; Electrocardiogram; Hypertension; Insulin

Indexed keywords

ADRENERGIC ACTIVITY; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031055976     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.85109000.x     Document Type: Article

References (27)

1. Cederholm J, Wibell L. The relationship of blood pressure to blood glucose and physical leisure time activity. Acta Med Scand 1986; 219: 37-46.
2. Pyörälä K, Savolainen E, Kaulola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9.5-year follow-up of the Helsinki policemen study population. Acta Med Scand 1985; 701 (Suppl.): 38-52.
3. Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S. Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. Br Med J 1988; 297; 960-63.
4. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independently of obesity. Metabolism 1990; 39: 167-74.
5. Ferrannini E, Buzzigoli G, Bonadonna R, Giorcio MA, Oleggini M, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-57.
6. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi A et al. A link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809-17.
7. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-7.
8. Gardin JM, Drayer JIM, Weber MA, Roham MK, Knoll M, Shu VWC et al. Doppier echocardiographic assessment of left ventricular systolic and diastolic function in mild hypertension. Hypertension 1987; 59 (Suppl. 2): 90-96.
9. Naimark BJ, Tate RB, Manfreda J, Stephens NL, Mymin D. The association between exercise blood pressure and the prevalence of ECG abnormalities. Can J Cardiol 1990; 7: 267-73.
10. Riggs TW, Transue D. Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus. Am J Cardiol 1990; 65: 899-902.
11. Ruddy TD, Shumak SL, Lius PP, Barnie A, Seawright SH, McLaughlin PR et al The relationship of cardiac diastolic dysfunction to concurrent hormonal and metabolic status in type 1 diabetes mellitus. J Clin Endocrinol Metab 1988; 66: 113-18.
12. Jermendy G, Koltai MZ, Pogásta G. QT interval prolongation in type 2 (non-insulin-dependent) diabetic patients with cardiac autonomie neuropathy. Acta Diabetol 1990; 27: 295-301.
13. Lind L, Hvarfner A, Pollare T,. Lithell S, Ljunghall S. Fasting insulin, calcium metabolism and the electrocardiogram in hypertensive subjects. J Intern Med 1992; 232: 335-9.
14. Blackburn H, Keys A, Simonson E. The electrocardiogram in population study. Circulation 1960; 21: 1160-70.
15. Bazette HC. Analysis of time relations of electrocardiograms. Heart 1920; 7: 353-60.
16. Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 1993; 21: 886-93.
17. Landsberg L. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986; 61: 1081-90.
18. Christensen NJ. Acute effects of insulin on cardiovascular function and noradrenaline uptake and release. Diabetologia 1983; 25: 377-81.
19. Flatt A, Crane J, Purdie T, Kwong R, Beasley R, Burgess C. The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. Postgrad Med J 1990; 66: 98-101.
20. Hansen O, Johansson BW, Gullberg B. Metabolic, hemodynamic, and electrocardiographic responses to increased circulating adrenaline: effects of pretreatment with Class 1 antiarrhythmics. Angiology 1991; 19: 990-1001.
21. Lucchesia BR, Medina M, Kniffen FJ. The positive inotropic action of insulin in the canine heart. Eur J Pharmacol 1972; 18: 107-11.
22. Thuesen L, Christiansen JS, Schmitz O, Christensen NJ, Orsko H, Henningsen P. Increased myocardial contractility during intravenous insulin infusion in type 1 (insulin-dependent) diabetic patients: an echocardiographic study. Scand J Clin Lab Invest 1988; 48: 275-84.
23. Vetter U, Kupferschmid C, Lang D, Pentz S. Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocyts in vitro. Basic Res Cardiol 1988; 83: 647-54.
24. Verdecchia P, Schillaci G, Guerrieri M, Boldrini F, Gatteschi G, Benemio G et al. Prevalence and determinants of left ventricular diastolic filling abnormalities in an unselected hypertensive population. Eur Heart J 1990; 11: 679-91.
25. Tibblin G, Wilhelmsen L, Werkö L. Risk factors for myocardial infarction and death du to ischaemic heart disease and other causes. Am J of Cardiology 1975; 35: 514-22.
26. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death; a 12 year follow up of participants in the population study of women in Gotheburg. Sweden. Br Med J 1984; 289: 1257-61.
27. Sheu WH-H, Jeng C-Y, Shieh S-M, Fuh MM-T, Shen DD-C, Ida Chen Y-D et al. Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am J Hypertens 1992; 5: 444-48.